Kinase inhibitors for the treatment of inflammatory and autoimmune disorders

被引：39

作者：

Bhagwat, Shripad S. ^{[1
]}

机构：

[1] Ambit Biosci, San Diego, CA 92121 USA

来源：

PURINERGIC SIGNALLING | 2009年 / 5卷 / 01期

关键词：

Kinase inhibitors; Anti-inflammatory agents; Autoimmune modulators; IKK2; inhibitors; Syk inhibitors; Lck inhibitors; JAK3; KAPPA-B KINASE; IKK-BETA INHIBITORS; POTENT; DISCOVERY; SYK; JAK3; LCK; SAR; DERIVATIVES; BMS-345541;

D O I：

10.1007/s11302-008-9117-z

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Drugs targeting inhibition of kinases for the treatment of inflammation and autoimmune disorders have become a major focus in the pharmaceutical and biotech industry. Multiple kinases from different pathways have been the targets of interest in this endeavor. This review describes some of the recent developments in the search for inhibitors of IKK2, Syk, Lck, and JAK3 kinases. It is anticipated that some of these compounds or newer inhibitors of these kinases will be approved for the treatment of rheumatoid arthritis, psoriasis, organ transplantation, and other autoimmune diseases.

引用

页码：107 / 115

页数：9

共 50 条

[1] Kinase inhibitors for the treatment of inflammatory and autoimmune disorders
Shripad S. Bhagwat
Purinergic Signalling, 2009, 5
[2] Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases
Zhang, Datong
Gong, He
Meng, Fancui
MOLECULES, 2021, 26 (16):
[3] Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors
Zheng, Jiamin
Wu, Jun
Ding, Xiao
Shen, Hong C.
Zou, Ge
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 38
[4] Protein-kinase inhibitors: A new treatment pathway for autoimmune and inflammatory diseases?
Hernandez-Florez, Diana
Valor, Lara
REUMATOLOGIA CLINICA, 2016, 12 (02): : 91 - 99
[5] Rho Kinase (ROCK) Inhibitors and Their Application to Inflammatory Disorders
LoGrasso, Philip V.
Feng, Yangbo
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (08) : 704 - 723
[6] Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors
Rahim, Kashif
Shan, Muhammad
Ul Haq, Ihtisham
Nawaz, Muhammad Naveed
Maryam, Sajida
Alturki, Mansour S.
Al Khzem, Abdulaziz H.
Metwally, Kamel
Cavalu, Simona
Alqifari, Saleh F.
Yahya, Galal
JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 1897 - 1917
[7] Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases
Tang, Su'an
Yu, Qinghong
Ding, Changhai
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (03) : 291 - 303
[8] Targeting IκB kinase for the treatment of inflammatory and other disorders
Burke, JR
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (05) : 720 - 728
[9] JAK3 inhibitors for the treatment of inflammatory and autoimmune diseases: a patent review (2016-present)
Chen, Chengjuan
Lu, Dianxiang
Sun, Tao
Zhang, Tiantai
EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (03) : 225 - 242
[10] Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders
Robak, Tadeusz
Robak, Ewa
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (07) : 921 - 947

← 1 2 3 4 5 →